July 7, 2022European Journal of Heart Failure50 citationsOpen Access
View Full PaperBiomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR –Preserved trial
Structured PICO
Does a combination of NT-proBNP, hs-cTnT, and clinical variables provide effective risk discrimination for morbidity and mortality in patients with HFpEF?
P
Population
Patients with chronic heart failure with preserved ejection fraction (HFpEF)
I
Intervention
Prognostic risk models combining NT-proBNP, hs-cTnT, and readily available clinical variables
O
Outcome
Risk discrimination for morbidity and mortalityhard clinical
A predictive tool-kit combining NT-proBNP, hs-cTnT, and clinical variables effectively discriminates morbidity and mortality risk in patients with HFpEF, facilitating implementation in routine clinical practice.
Abstract
The combination of NT-proBNP and hs-cTnT along with a few readily available clinical variables provides effective risk discrimination both for morbidity and mortality in patients with HFpEF. A predictive tool-kit facilitates the ready implementation of these risk models in routine clinical practice.